Controlling Myopia Progression With Soft Contact Lenses
NCT ID: NCT01787760
Last Updated: 2018-06-19
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
221 participants
INTERVENTIONAL
2007-04-01
2010-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Comparison of Two Soft Contact Lenses (C24-755)
NCT06758076
A 2-year Longitudinal Study on the Structural and Optical Effects of Orthokeratology Treatment on Eye
NCT02643342
Marketed Contact Lens Real World Through Focus Curve
NCT02679976
Clinical Investigation of a Small Aperture Extended Depth of Focus Intraocular Lens in Patients With Complex Corneas
NCT05574270
Evaluation of Soft Multifocal Lenses in Presbyopic Previous Contact Lens Wearers
NCT06053463
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Test Soft Contact Lens B
Lenses will be worn in a daily disposable modality
Test Soft Contact Lens B
Test lenses to be worn in daily wear modality
Test Soft Contact Lens C
Lenses will be worn in a daily disposable modality
Test Soft Contact Lens C
Test lenses to be worn in a daily wear modality
Spectacle Lenses
Control spectacle lenses worn daily.
Active Comparator
Control spectacle lenses to be worn in a daily wear modality
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Test Soft Contact Lens B
Test lenses to be worn in daily wear modality
Test Soft Contact Lens C
Test lenses to be worn in a daily wear modality
Active Comparator
Control spectacle lenses to be worn in a daily wear modality
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. The subject's best sphere contact lens correction must lie between -0.75D (best of the two eyes) and -5.00D (worst of the two eyes)
3. Astigmatism must be less than or equal to 1.00D
4. Less than 1.00D difference in spherical equivalent between the two eyes
5. The subject must have a best-corrected visual acuity of 20/25 and spherical equivalent refraction visual acuity of 20/25 or better in both eyes
6. The subject must have at least 8D of accommodation.
7. The subject's parent or legal guardian must read and sign the STATEMENT OF INFORMED CONSENT and the subject must read and sign the Child's Assent Form and be provided a copy of each form
8. The subject must appear able and willing to adhere to the instructions set forth in the clinical protocol
Exclusion Criteria
2. Systemic disease or autoimmune disease or use of medication (e.g. antihistamines), which may interfere with contact lens wear.
3. Clinically significant (grade 3 or 4) tarsal abnormalities or bulbar injection that might interfere with contact lens wear.
4. Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal staining, or any other abnormality of the cornea, which may contraindicate contact lens wear.
5. Any ocular infection.
6. Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
7. Any infectious disease (e.g. hepatitis, tuberculosis) or immunosuppressive disease (e.g. HIV).
8. Diabetes.
9. Anismetropia.
10. Astigmatism of greater than 1.00D in either eye.
11. Eye injury or eye surgery within eight weeks immediately prior to enrollment for this study.
12. Previous refractive surgery, rigid contact lens wear, orthokeratology, keratoconus, or other corneal irregularity in either eye
13. Strabismus in either eye
14. Pupil or lid abnormality or infection in either eye
15. Central corneal scar and aphakia in either eye
16. Contraindications to contact lens wear such as dry eye or history of prior unsuccessful contact lens wear
17. History of participation in clinical trials aimed to control myopia progression
18. Surgically altered eyes, ocular infection of any type, ocular inflammation
19. Subject has anterior chamber angle grade 2 or narrower
8 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johnson & Johnson Vision Care, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Hong Kong Polytechnic University
Hung Hom, Kowloon, Hong Kong
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CR-1561AC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.